Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone

NCT01513174 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Gefitinib
DRUG: Olaparib

Sponsor

Spanish Lung Cancer Group